“As the mother of a black child – having to talk to my 10-year-old son about ongoing racism is heartbreaking for me,” said Andrea N. Taylor, PhD, adult psychologist with UT Physicians and UTHealth.
Social isolation necessitated by COVID-19 weighs on everyone, especially older adults and those living with disabilities who may have already felt relatively isolated before the pandemic even started, said Greg Shelley, program manager of the Harris County Long-term Care Ombudsman Program at Cizik School of Nursing at The University of Texas Health Science Center at Houston (UTHealth). Likewise, the staff and volunteers who are dedicated to advocating for rights, health, and safety of seniors miss face-to-face visits.
COVID-19 has changed the way families go about their daily routines. With public schools being closed, most parents now have to take on several roles at once. Most are working, providing home schooling and care during the day, and taking on other new roles.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
As the number of COVID-19 cases continues to rise in the U.S., a new free research app is hoping to slow the outbreak of the disease by tracking symptoms of millions across the country. To bring the app home to Texans, researchers at The University of Texas Health Science Center at Houston (UTHealth) have joined the national research project led by Harvard University.
Real-time data about health and health care during the COVID-19 pandemic can help contain the virus but has been difficult to obtain. A new paper published in JAMA explores the concept of a national health information technology (IT) infrastructure to provide up-to-date patient information in public health emergencies, which can then be used in planning and containment efforts.
MTX110 is a new formulation of panobinostat, a chemotherapy drug that has shown promise in laboratory models of medulloblastoma, the most common malignant brain tumor in children. Now, MTX110 is the focus of a novel trial that places the therapy directly into the fourth ventricle of the brain to treat patients with recurrent medulloblastoma.
The Stay Home, Work Safe order has been lifted across the state, but with so much uncertainty still lingering around COVID-19, many patients may be wary of attending their much-needed appointments, potentially putting themselves at risk for worsening their condition.
Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at UTHealth. Cap-based Transcranial Optical Tomography (CTOT), which utilizes a cap for the baby’s head, is the first high-resolution, whole-brain functional imaging device that does not require the baby to be put under anesthesia.
First responders in Texas can now call a confidential helpline to seek treatment for substance use and mental health disorders through a new clinical research program at The University of Texas Health Science Center at Houston (UTHealth). The Heroes Helpline comes at a time when first responders are serving on the front lines of the COVID-19 pandemic.
As officials consider how to reopen the country safely, researchers say antibody testing will play an important role in navigating those future decisions. But not all antibody tests are created equal, and the presence of antibodies doesn’t necessarily equate to COVID-19 immunity.
A dashboard developed by experts at The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics takes a new look into local, national, and global cases of COVID-19 to offer better insights from currently available data.
In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The case was published April 22 in the New England Journal of Medicine.
The University of Texas Health Science Center at Houston (UTHealth) has teamed up with the White House Office of Science and Technology Policy and the National Institute of Standards and Technology (NIST) to develop search engines that will help streamline COVID-19 research for health care experts fighting the virus.
As local, state, and national government leaders release guidelines on reopening businesses and returning to a “new normal” during the COVID-19 pandemic, public health and infectious disease experts at The University of Texas Health Science Center at Houston (UTHealth) say a gradual, cautious return would be the most effective.
Many individuals with autism spectrum disorder (ASD) struggle with finding and maintaining employment, which is an important key to helping them achieve lifelong success. To create a bridge toward employment, the Benjamin J. Geigerman Lecture Series was created at UTHealth.
The first COVID-19 patient in Texas has been enrolled in a stem cell therapy clinical trial for acute respiratory distress syndrome (ARDS) at The University of Texas Health Science Center at Houston (UTHealth).
Research has shown long-duration spaceflight missions impact the vision of astronauts. Now a new study, published today in the journal Radiology, shows extended time in space also alters brain and pituitary structure.
An experimental therapy to help patients recover from COVID-19 by transfusing plasma from virus survivors into critically ill patients is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth) for use at Memorial Hermann.
Areas within Texas’ major metropolitan cities where residents are at the greatest risk for hospitalization and critical care due to COVID-19 have been mapped for the first time by researchers at The University of Texas Health Science Center at Houston (UTHealth).
There are some critical things to know about how to use a nonmedical mask correctly, because when used incorrectly, which is pretty easy to do, you could actually put yourself and others more at risk. Physicians at UTHealth break it all down.
Because COVID-19 attacks the lungs, limiting social contact is extremely important for people who have underlying health conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and any additional chronic lung illness.
COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions, according to a review published today in JAMA Cardiology by experts at The University of Texas Health Science Center at Houston (UTHealth).
Led by Eric Boerwinkle, PhD, and Momiao Xiong, PhD, The University of Texas Health Science Center at Houston (UTHealth) modeled the potential spread of COVID-19 based on whether the Greater Houston area began stringent interventions immediately or waited one week or two weeks. That data was presented Monday to city and county officials.
Areas of Harris County, Texas, where residents are most at risk for hospitalization and critical care needs due to COVID-19 have been mapped for the first time by researchers at The University of Texas Health Science Center of Houston (UTHealth).
According to the CDC, based on the preliminary report on outcomes for patients in the U.S., when examining the age range of cases, the largest group with confirmed cases was ages 20-44 years old (29%). Among those hospitalized, adults ages 65-84 years old comprised over a third of patients, but young people were not immune; 1 in 5 of those needing hospitalization were between the ages of 20 and 44 years old. The CDC also reports that in cases with known outcomes, 20% of the deaths occurred in those ages 20-64 years old.
Since the outbreak of COVID-19, rumors and misinformation about the virus seem to be spreading just as quickly, if not more quickly, than the virus itself. In the midst of a pandemic, false information can be dangerous and lead to panic, making it difficult to differentiate between fact and fiction.
As COVID-19 continues to spread across the U.S., social distancing is now the byword for prevention. But for older adults who may already be experiencing loneliness, further isolation could be bad for their health.
While we are all focusing on taking care of our physical health as the outbreak of COVID-19 develops, it’s also important to keep our mental health a priority.
The list of schools canceling classes indefinitely is growing, and day-to-day life has been disrupted like never before – all because of increased social distancing measures to stop the spread of COVID-19. This lack of routine, coupled with the fear of an unknown illness, can be overwhelming for children. A pediatric psychologist with the Children’s Learning Institute at The University of Texas Health Science Center at Houston (UTHealth) explains what parents can do to maintain a sense of normalcy for their children during this time.
Three programs at Cizik School of Nursing at The University of Texas Health Science Center at Houston (UTHealth) made the 2021 list of Best Graduate Schools published today by U.S. News & World Report.
As COVID-19 continues to spread across the globe, many are starting to consider scaling back exposure to people, a tactic called “social distancing” and a buzz phrase for people closely following the pandemic. Much to the delight of germophobes and introverts, epidemiologists say social distancing can help prevent the spread of disease.
Researchers who discovered that an engineered cold sore virus could help destroy brain tumors from the inside out have determined a one-two punch might be the key to finish them off. This virotherapy could make a class of investigational cancer drugs more effective, according to investigators at UTHealth.
Proactive outreach, including knocking on the doors of individuals who recently overdosed on opioids, can be an effective way to engage more people who have opioid use disorder with long-term care, according to researchers at UTHealth.
Timely treatment is critical for stroke victims, yet only 19.8% of the U.S. population can access a stroke center capable of endovascular thrombectomy to remove a large clot in 15 minutes or less by ambulance, according to researchers from UTHealth. Only 30% of Americans can access a thrombectomy-equipped center in 30 minutes.
Decreased folate levels in the bloodstream have been associated with an increased risk of cardiovascular mortality in patients with rheumatoid arthritis, shedding light on why those patients are more susceptible to heart and vascular disease, according to research published today in JAMA Network Open by experts at The University of Texas Health Science Center at Houston (UTHealth).
More than 10,000 uninsured patients sought care at Texas emergency departments for lifesaving kidney dialysis in 2017, incurring more than $21.8 million in hospital costs, according to researchers from UTHealth.
Louise D. McCullough, MD, PhD, a physician-scientist at UTHealth is a recipient of the American Heart Association’s (AHA) prestigious $1 million Merit Award to investigate whether the maternal microbiome influences stroke risk in offspring.
A broken heart for Valentine’s Day sounds like the plot of a romantic comedy. But for Rebekah Holl, a literal broken heart was her reality on Feb. 14, 2019. Born with a rare defect called d-Transposition of the Great Arteries, she underwent open-heart surgery as an infant to correct the way blood circulates throughout her body. Though rare, congenital heart defects are the most common form of birth defects – affecting about 1% or 40,000 births per year in the U.S.
Lowering the risk of developing a life-threatening condition while pregnant is as simple as taking low-dose aspirin every day, according to OB-GYNs at UTHealth. They are now recommending their patients take a low-dose aspirin of 81 milligrams daily to prevent preeclampsia as part of routine prenatal care, just like taking a prenatal vitamin.
Scientists have found a way to distinguish between two progressive neurodegenerative diseases, Parkinson’s disease (PD) and multiple system atrophy (MSA), using a technology developed by a researcher at UTHealth. The discovery was published today in Nature.
The Children’s Learning Institute at The University of Texas Health Science Center at Houston (UTHealth) has received a $3 million grant to teach the latest child development strategies to more than 850 infant and toddler specialists and teachers working in at-risk communities in the Lone Star State.
In response to the youth vaping crisis, experts at The University of Texas Health Science Center at Houston (UTHealth) developed CATCH My Breath, a program to prevent electronic cigarette use among fifth – 12th grade students. Research published in Public Health Reports reveals the program significantly reduces the likelihood of e-cigarette use among students who complete the curriculum.
The grim effects that climate change will have on pediatric health outcomes was the focus of a “Viewpoint” article published in the Journal of Clinical Investigation by Susan E. Pacheco, MD, an expert at The University of Texas Health Science Center at Houston (UTHealth).
Both simple and advanced computed tomography (CT) were effective in accurately predicting which stroke patients would benefit from endovascular thrombectomy to remove a large cerebral clot, but together they were even better, reported researchers at UTHealth in Houston.
To make sure historically undercounted populations along the Texas-Mexico border are included in the 2020 census, faculty at The University of Texas Health Science Center at Houston (UTHealth) are joining forces with the U.S. Census Bureau, community health workers, and local organizations to launch a collaborative campaign in the El Paso region.